Method for fast screening mammal cell strain having high exogenous protein expression level

A mammalian and cell technology, applied in the direction of cells modified by introducing foreign genetic material, introducing foreign genetic material using a vector, recombinant DNA technology, etc., can solve the problems of restricting large-scale production of recombinant protein drugs, time-consuming and cost, etc. Achieve the effect of saving development cost and time, reducing the probability of false positive clones, and improving screening efficiency

Active Publication Date: 2014-10-08
UNICOHEALTH CO LTD
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, conventional screening methods need to select stable monoclonal cells with high expression from tens of thousands of cells, and the process of obtaining stable high-expression cell lines takes at least half a year, which consumes a lot of time and cost, and restricts the large-scale production of recombinant protein drugs. mass production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for fast screening mammal cell strain having high exogenous protein expression level
  • Method for fast screening mammal cell strain having high exogenous protein expression level
  • Method for fast screening mammal cell strain having high exogenous protein expression level

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: Construction of mammalian cell expression vector

[0048] Methods: The traditional expression vector pA was constructed by molecular biology techniques, such as restriction enzyme digestion, DNA ligation, Escherichia coli transformation and clone screening, according to the standard methods of "Molecular Cloning Experiment Guide" (third edition, translated by Huang Peitang, Science Press) and the expression vector pB of the present invention. The specific operation method is as follows:

[0049] 1.1 Construction of the traditional expression vector pA: the pcDNA3.1 vector of Invitrogen Company was used as the template.

[0050] The fusion sequence (1.8kb) of promoter SV40, DHFR, terminator sv40 and other regulatory sequences was artificially synthesized, and speI and NaeI enzyme cutting sites were added at its ends, respectively. The synthetic fusion sequence was ligated to pcDNA3.1 digested by speI and NaeI using T4DNA ligase, transformed into Escherich...

Embodiment 2

[0077] Example 2: Rapid screening of stable cell lines expressing EPO protein

[0078] 2.1. Construct the expression vector containing the target gene: artificially synthesize the coding sequence of EPO according to the existing sequence information of NCBI, and clone it into the expression vector pA constructed in Example 1 by introducing the corresponding restriction sites (NheI and HindIII) and pB, the expression plasmids pA-EPO and pB-EPO containing the target gene were obtained.

[0079] 2.2. DNA transfection into CHO-dhfr - Suspension cell lines: Transfect the above-mentioned expression plasmids pA-EPO and pB-EPO containing the target gene, and the expression vector control pA and pB into DHFR enzyme-deficient CHO cells (CHO-dhfr - )middle. CHO-dhfr - The cells were cultured in suspension, and the cell density was 1.5×10 6 / ml, the transfection volume was 30ml. The transfection method was operated according to the instruction of Lipofectamine2000 (purchased from Inv...

Embodiment 3

[0097] Embodiment 3: the comparison of EPO protein expression level in different host cells

[0098] Method: The expression vectors pA and pB constructed in Example 1 and the expression plasmids pA-EPO and pB-EPO containing the target gene EPO constructed in Example 2 were transfected into the following three host cells, including CHO-dhfr cells, BHK cells and HEK293 cells. The transfection method and the screening method for obtaining stable cell lines are the same as those in Example 2.

[0099] Results: Through Western Blotting and ELISA analysis, the expression of the target protein was not detected in the negative control (pA, pB) transfected cells, so the stable cell line containing EPO could not be screened. Compared with the negative control, the host cells transfected with expression plasmids pA-EPO and pB-EPO containing the target gene EPO obtained six kinds of stable cell lines through screening, and the ELISA analysis results showed that in the traditional screeni...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for fast screening a mammal cell strain having a high exogenous protein expression level. The method utilizes a novel high-expression carrier, realizes efficient expression of a desired protein in an appropriate mammal host cell, and realizes fast screening of a cell strain having a high desired protein expression level by a unique screening method. The method greatly reduces time and a cost of screening of the cell strain having a high desired protein expression level and substantially improves an expression level of the exogenous protein in the mammal host cell.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a method for rapidly screening stable high-yield mammalian cell lines. The screening method of the invention can quickly obtain a stable mammalian cell line highly expressing the foreign protein. Background technique [0002] With the development of biomedical technology, therapeutic recombinant proteins (including antibodies) have been widely used in clinical practice. Many therapeutic recombinant proteins often require specific post-translational modifications, such as glycosylation, to maintain their biological activity, while prokaryotic or low-level eukaryotic cell expression systems lack complex post-translational modification functions. With the gradual popularization of glycoprotein drugs, mammalian expression system, especially CHO cell (Chinese hamster ovary, Chinese hamster ovary cell) expression system is becoming the most important host cell for the producti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85C12N5/10
Inventor 侯永敏李强李屹晨雷瑶
Owner UNICOHEALTH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap